Skip to main content

What the label lists and what reports show

Hydrocodone side effects

Hydrocodone's FDA label: “Most common treatment-emergent adverse events (incidence ≥ 5%) are constipation, nausea, vomiting, fatigue, upper respiratory tract infection, dizziness, headache, and somnolence.” FAERS holds 43,191 reports naming it through July 30, 2026; the reaction reported most often, leaving out the conditions it is used for, product-use terms and outcomes, is drug dependence (10,364 reports).

  • Generic listed
  • Boxed warning
  • DEA Schedule II

Check it at the source: the hydrocodone FDA label on DailyMed (effective May 29, 2026); the FDA FAERS public dashboard.

What does the label list?

From the label: adverse reactions

Most common treatment-emergent adverse events (incidence ≥ 5%) are constipation, nausea, vomiting, fatigue, upper respiratory tract infection, dizziness, headache, and somnolence.

Table 2: Adverse Reactions Reported in ≥2% of Patients during the Open-Label Titration Period and Double-Blind Treatment Period: Patients Who Were Not Opioid Tolerant and Opioid-Experienced Patients

MedDRA Preferred Term(N=905) (%)Placebo (N=292) (%)HYSINGLA ER (N=296) (%)
Nausea1658
Constipation923
Vomiting736
Dizziness723
Headache722
Somnolence511
Fatigue411
Pruritus3<10
Tinnitus212
Insomnia223
Decreased appetite112
Influenza113

Rows and numbers as the label prints them, under its own column headings (the first rows of a longer table where it runs on). A reaction in a trial table is not necessarily caused by the medicine, and trials differ from everyday use.

From the label: adverse reactions, continued

The following serious adverse reactions are described elsewhere in the labeling: Addiction, Abuse, and Misuse [see Warnings and Precautions (5.1) ] Life-Threatening Respiratory Depression [see Warnings and Precautions (5.2) ] Interactions with Benzodiazepine or Other CNS Depressants [see Warnings and Precautions (5.3) ] Neonatal Opioid Withdrawal Syndrome [see Warnings and Precautions (5.4) ] Opioid-Induced Hyperalgesia and Allodynia [see Warnings and Precautions (5.7) ] Adrenal Insufficiency [see Warnings and Precautions (5.9) ] Severe Hypotension [see Warnings and Precautions (5.10) ] Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.13 , 5.14) ] Seizures [see Warnings and Precautions (5.15) ] Withdrawal [see Warnings and Precautions (5.16) ] Most common treatment-emergent adverse events (incidence ≥ 5%) are constipation, nausea, vomiting, fatigue, upper respiratory tract infection, dizziness, headache, and somnolence. ( 6.1 ) To report SUSPECTED ADVERSE REACTIONS, contact Knoa Pharma LLC at 1-888-726-7535 or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. 6.1 Clinical Trial Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice. …

Source: FDA drug label, Knoa Pharma LLC, effective May 29, 2026 (SPL set b7d23ac2-e776-9f62-3290-c64c2d6eb353), via openFDA; the full label on DailyMed

What do FAERS reports show?

43,191 reports list hydrocodone among the medicines taken, each a report of something that happened, not proof the medicine caused it; 21,422 are coded as a death and 4,422 as a hospital stay. Counts follow how widely a medicine is used and watched, and they are not a measure of how risky it is. Reports rose sharply in 2018 (21,042, against a median of 918 a year): FAERS counts follow reporting, which news, litigation and label changes can drive, not how often a reaction happens. Of the 18 reactions below, 9 are named by the same term (in US spelling) in the label's adverse reactions, warnings or patient leaflet; a reaction the label does not name may still be there under another word, and a report does not show that the medicine caused it.

Reports received each year

The 25 most reported reactions

  • Death (an outcome recorded in the report)11,932
  • Drug Dependence10,364
  • Overdose (a use or a product term, not a reaction)9,662
  • Toxicity To Various Agents9,510
  • Pain (a use or a product term, not a reaction)7,321
  • Emotional Distress6,721
  • Drug Withdrawal Syndrome5,578
  • Drug Abuse (named in the label)1,776
  • Drug Withdrawal Syndrome Neonatal1,290
  • Nausea (named in the label)1,062
  • Anxiety (named in the label)973
  • Drug Ineffective (a use or a product term, not a reaction)912
  • Accidental Overdose (a use or a product term, not a reaction)754
  • Depression751
  • Headache (named in the label)602
  • Fatigue (named in the label)543
  • Vomiting (named in the label)524
  • Drug Diversion510
  • Dizziness (named in the label)497
  • Dyspnoea470
  • Diarrhoea (named in the label)450
  • Foetal Exposure During Pregnancy (a use or a product term, not a reaction)413
  • Insomnia (named in the label)398
  • Maternal Exposure During Pregnancy (a use or a product term, not a reaction)373
  • Fall368

Source: FDA Adverse Event Reporting System (FAERS) via openFDA, reports through July 30, 2026; reactions as MedDRA preferred terms

What next?

Hydrocodone: the full record
label, generics, price, shortages, recalls
Side effects hub
the most reported medicines and reactions